Your Rights as an AGEN Shareholder
If you're a shareholder of Agenus Inc., it's crucial to stay updated and take action regarding your rights—especially with recent allegations about the company's performance. The Gross Law Firm has contacted investors to share important information for those who bought shares of AGEN during the specified class period. Being well-informed can enable you to make thoughtful choices about your investments.
Details on the Class Period and Allegations
The class period in question stretches from January 23, 2023, to July 17, 2024. Throughout this period, allegations indicate that the defendants made significant misleading statements concerning the effectiveness of their immuno-oncology products, particularly the combination therapy of botensilimab and balstilimab. These claims have raised red flags about the accuracy of clinical results and the overall commercial viability, which were reportedly exaggerated.
Implications for Investors
If you purchased shares of AGEN within this timeframe, you might be eligible to join the class action that aims to address the discrepancies caused by these misleading statements. Participating in this legal action could help you recover any losses stemming from the misinformation.
Key Dates for Shareholders
Time is critical for shareholders looking to take part in this case. The cutoff date for registering as a lead plaintiff is November 5, 2024. Timely registration is vital to ensure that your rights are safeguarded within the class action framework. The process is simple and allows participation without any fees.
Steps to Get Involved
If you choose to take part in this legal process, the Gross Law Firm offers portfolio monitoring software to keep you informed about your case status. Each participant will receive important updates as the class action develops, reflecting the firm's commitment to transparency and support for their clients.
The Gross Law Firm's Commitment
Recognized nationwide for advocating investor rights, the Gross Law Firm focuses on holding companies accountable for any fraudulent or deceptive actions. Their mission goes beyond just legal recovery; they also aim to promote responsible corporate behavior.
How to Contact the Firm
If you need more clarity or assistance with your situation, it's a good idea to reach out to the Gross Law Firm. They provide various ways to communicate, including email and phone support, ensuring that all client inquiries are thoroughly addressed. This level of attention highlights their dedication to client service and legal advocacy.
Frequently Asked Questions
What is the deadline to register for the class action?
The cut-off date for shareholders looking to register as a lead plaintiff is November 5, 2024.
Why is it important to register for the class action?
Registering gives you a chance to potentially recover losses that may have arisen from the misleading statements made by the company during the class period.
What allegations have been made against Agenus Inc.?
The primary allegations suggest that the company overstated the effectiveness of its immuno-oncology products and did not disclose relevant information to investors.
How will I stay informed about my case's progress?
The Gross Law Firm keeps you updated through their portfolio monitoring software after you register, ensuring you're informed throughout the litigation process.
What should I do if I have more questions?
If you have additional inquiries, it's best to contact the Gross Law Firm directly via phone or their official email for personalized assistance.